30 Day Trial

Vericel Posts Record Growth in 2Q19 on New Surgeons

Share:

Vericel reports 2Q19 MACI revenue of USD $20.8MM, +47.5% vs. 2Q18.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.